Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Diagnostic Imaging Unit, National Center of Oncological Hadrontherapy (CNAO), Pavia, Italy.
Neuroradiology. 2021 Jul;63(7):1053-1060. doi: 10.1007/s00234-020-02630-6. Epub 2021 Jan 3.
To assess early microstructural changes of meningiomas treated with proton therapy through quantitative analysis of intravoxel incoherent motion (IVIM) and diffusion-weighted imaging (DWI) parameters.
Seventeen subjects with meningiomas that were eligible for proton therapy treatment were retrospectively enrolled. Each subject underwent a magnetic resonance imaging (MRI) including DWI sequences and IVIM assessments at baseline, immediately before the 1st (t0), 10th (t10), 20th (t20), and 30th (t30) treatment fraction and at follow-up. Manual tumor contours were drawn on T2-weighted images by two expert neuroradiologists and then rigidly registered to DWI images. Median values of the apparent diffusion coefficient (ADC), true diffusion (D), pseudo-diffusion (D*), and perfusion fraction (f) were extracted at all timepoints. Statistical analysis was performed using the pairwise Wilcoxon test.
Statistically significant differences from baseline to follow-up were found for ADC, D, and D* values, with a progressive increase in ADC and D in conjunction with a progressive decrease in D*. MRI during treatment showed statistically significant differences in D values between t0 and t20 (p = 0.03) and t0 and t30 (p = 0.02), and for ADC values between t0 and t20 (p = 0.04), t10 and t20 (p = 0.02), and t10 and t30 (p = 0.035). Subjects that showed a volume reduction greater than 15% of the baseline tumor size at follow-up showed early D changes, whereas ADC changes were not statistically significant.
IVIM appears to be a useful tool for detecting early microstructural changes within meningiomas treated with proton therapy and may potentially be able to predict tumor response.
通过分析瘤内各向异性扩散(IVIM)和弥散加权成像(DWI)参数,评估质子治疗脑膜瘤的早期微观结构变化。
回顾性纳入 17 例符合质子治疗条件的脑膜瘤患者。每位患者均接受包括 DWI 序列和 IVIM 评估的磁共振成像(MRI)检查,基线时、第 1 次(t0)治疗前、第 10 次(t10)、第 20 次(t20)和第 30 次(t30)治疗前以及随访时进行。由 2 名神经放射学专家在 T2 加权图像上手动勾画肿瘤轮廓,然后将其刚性配准到 DWI 图像上。在所有时间点提取表观扩散系数(ADC)、真实扩散(D)、假性扩散(D*)和灌注分数(f)的中位数。采用配对 Wilcoxon 检验进行统计学分析。
与基线相比,ADC、D 和 D值在随访时均有统计学意义的差异,ADC 和 D 逐渐增加,而 D逐渐降低。治疗期间的 MRI 显示,D 值在 t0 与 t20(p=0.03)和 t0 与 t30(p=0.02)之间以及 ADC 值在 t0 与 t20(p=0.04)、t10 与 t20(p=0.02)和 t10 与 t30(p=0.035)之间均有统计学意义的差异。在随访时肿瘤体积较基线减少大于 15%的患者,其 D 值变化较早,而 ADC 值变化无统计学意义。
IVIM 似乎是一种有用的工具,可用于检测质子治疗脑膜瘤的早期微观结构变化,并且可能能够预测肿瘤反应。